October 5-6, 2011
London
C5
C5’s 21st Forum on Biotech Patenting brings together eminent in-house counsel from the world’s largest pharma and biotech companies and their expert legal advisors from a range of European, U.S. and emerging market jurisdictions. Finnegan's Elizabeth Doherty will present “How to Navigate through Antibody Claims and Personalized Medicine/Biomarkers in the U.S.” The conference will be held at the Sheraton Park Lane Hotel in London, England. For more information, or to register, please see C5’s website.
At the PTAB Blog
Discretion All the Way Down: USPTO Uses a Discretionary IPR Denial to Justify a
§ 325(d) EPR Denial
May 28, 2026
At the PTAB Blog
IPR and PGR Statistics for Final Written Decisions Issued in March and April 2026
May 26, 2026
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.